These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 8791118)

  • 21. Surrogate end-point biomarker analysis in a retinol chemoprevention trial in current and former smokers with bronchial dysplasia.
    Lam S; Xu X; Parker-Klein H; Le Riche JC; Macaulay C; Guillaud M; Coldman A; Gazdar A; Lotan R
    Int J Oncol; 2003 Dec; 23(6):1607-13. PubMed ID: 14612933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stopping the active intervention: CARET.
    Bowen DJ; Thornquist M; Anderson K; Barnett M; Powell C; Goodman G; Omenn G;
    Control Clin Trials; 2003 Feb; 24(1):39-50. PubMed ID: 12559641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitamin A and cancer prevention II: comparison of the effects of retinol and beta-carotene.
    de Klerk NH; Musk AW; Ambrosini GL; Eccles JL; Hansen J; Olsen N; Watts VL; Lund HG; Pang SC; Beilby J; Hobbs MS
    Int J Cancer; 1998 Jan; 75(3):362-7. PubMed ID: 9455794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Statistical design and monitoring of the Carotene and Retinol Efficacy Trial (CARET).
    Thornquist MD; Omenn GS; Goodman GE; Grizzle JE; Rosenstock L; Barnhart S; Anderson GL; Hammar S; Balmes J; Cherniack M
    Control Clin Trials; 1993 Aug; 14(4):308-24. PubMed ID: 8365195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Re: Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy trial.
    Challem JJ
    J Natl Cancer Inst; 1997 Feb; 89(4):325-6. PubMed ID: 9048840
    [No Abstract]   [Full Text] [Related]  

  • 26. Chemoprevention of lung cancer: the rise and demise of beta-carotene.
    Omenn GS
    Annu Rev Public Health; 1998; 19():73-99. PubMed ID: 9611613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Strategies for recruitment to a population-based lung cancer prevention trial: the CARET experience with heavy smokers. Beta-Carotene and Retinol Efficacy Trial.
    Goodman GE; Valanis B; Meyskens FL; Williams JH; Metch BJ; Thornquist MD; Omenn GS
    Cancer Epidemiol Biomarkers Prev; 1998 May; 7(5):405-12. PubMed ID: 9610790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ["Good" and "bad" beta-carotene?].
    Thiberville L; Nouvet G
    Rev Mal Respir; 1996 Oct; 13(5):538. PubMed ID: 8999486
    [No Abstract]   [Full Text] [Related]  

  • 29. Changes in cholesterol and triglyceride concentrations in the Vanguard population of the Carotene and Retinol Efficacy Trial (CARET).
    Cartmel B; Dziura J; Cullen MR; Vegso S; Omenn GS; Goodman GE; Redlich CA
    Eur J Clin Nutr; 2005 Oct; 59(10):1173-80. PubMed ID: 16015255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of lung cancer.
    Goodman GE
    Crit Rev Oncol Hematol; 2000 Mar; 33(3):187-97. PubMed ID: 10789492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemoprevention or antichemoprevention? A salutary warning From the beta-carotene experience.
    Paolini M; Abdel-Rahman SZ; Cantelli-Forti G; Legator MS
    J Natl Cancer Inst; 2001 Jul; 93(14):1110-1. PubMed ID: 11459875
    [No Abstract]   [Full Text] [Related]  

  • 32. The association between lung and prostate cancer risk, and serum micronutrients: results and lessons learned from beta-carotene and retinol efficacy trial.
    Goodman GE; Schaffer S; Omenn GS; Chen C; King I
    Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):518-26. PubMed ID: 12814997
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A double-blind randomized trial with beta-carotene and retinol in persons at high risk of lung cancer due to occupational asbestos exposures and/or cigarette smoking.
    Omenn GS
    Public Health Rev; 1988; 16(1-2):99-125. PubMed ID: 3073436
    [No Abstract]   [Full Text] [Related]  

  • 34. The role of intervention studies in ascertaining the contribution of dietary factors in lung cancer. The Seattle chemoprevention trial of retinoids in asbestos-exposed workers.
    Omenn GS; Goodman GE; Kleinman GD; Rosenstock L; Barnhart S; Feigl P; Thomas DB; Kalman D; Lund B; Prentice RL
    Ann N Y Acad Sci; 1988; 534():575-83. PubMed ID: 3389681
    [No Abstract]   [Full Text] [Related]  

  • 35. The protective effect of beta-carotene and retinol on ventilatory function in an asbestos-exposed cohort.
    Chuwers P; Barnhart S; Blanc P; Brodkin CA; Cullen M; Kelly T; Keogh J; Omenn G; Williams J; Balmes JR
    Am J Respir Crit Care Med; 1997 Mar; 155(3):1066-71. PubMed ID: 9116988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does CARET reduce lung cancer and heart disease?
    Vaidya JS
    Natl Med J India; 1997; 10(1):47. PubMed ID: 9069714
    [No Abstract]   [Full Text] [Related]  

  • 37. The CARET asbestos-exposed cohort: baseline characteristics and comparison to other asbestos-exposed cohorts.
    Barnhart S; Keogh J; Cullen MR; Brodkin C; Liu D; Goodman G; Valanis B; Glass A; Thornquist M; Rosenstock L; Omenn G; Balmes J
    Am J Ind Med; 1997 Dec; 32(6):573-81. PubMed ID: 9358912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between asbestos exposure, cigarette smoking, myeloperoxidase (MPO) genotypes, and lung cancer risk.
    Schabath MB; Spitz MR; Delclos GL; Gunn GB; Whitehead LW; Wu X
    Am J Ind Med; 2002 Jul; 42(1):29-37. PubMed ID: 12111688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of participant retention in two chemoprevention feasibility trials.
    Bowen DJ; Cartmel B; Barnett M; Goodman G; Omenn GS
    Ann Behav Med; 1999; 21(3):210-5. PubMed ID: 10626026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Problem of cigarette smoking in the epidemiological studies of lung cancer risks among industrial populations].
    Szeszenia-Dabrowska N; Wilczyńska U
    Przegl Epidemiol; 1989; 43(3):283-8. PubMed ID: 2616801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.